• High Resolution
Intelligent content targets most relevant regions and provides genome-wide coverage with down to 1.2 kb marker spacing
• Easy Workflows Fast, simple, and proven sample preparation protocols, automated processing, and data readout
• User-Friendly Software Support Analysis and visualization programs offer an open architecture to support integration with other downstream analysis tools
Structural Variation and Phenotype
In addition to SNPs, structural variability is recognized as a substantial source of genetic variation having major influence on phenotypic changes. Thus, genome-wide profiling for chromosomal aberrationsamplifications, deletions, and rearrangements-is crucial for both the study of cancer and congenital disorders.
Illumina offers the iScan system and a portfolio of advanced Infinium DNA Analysis BeadChips to improve researchers' ability to identify and measure important cytogenetic variants, including point mutations, copy number variation (CNV), and rearrangements ( Figures 1 and 2 ). This platform enables detection of smaller regions than previous methods such as FISH or CGH. Additionally, Infinium BeadChips are easier to use and more efficient than array-CGH. The 12-sample Infinium HumanCytoSNP-12 BeadChip is a whole-genome scanning panel for high sample throughput analysis of genetic and structural variation, designed for streamlined routine cytogenetics screening. The Infinium HumanOmniExpress and Infinium HumanOmni2.5-8 BeadChips, as well as their exome versions, feature up to 2.4 million whole-genome SNP and CNV markers that are ideal for profiling structural variation in high-value functional regions (Table 1) .
Profiling Structural Aberrations
Illumina analysis products can detect many classes and sizes of structural variation in the human genome that affect phenotypes.
Duplications, Deletions, and Amplifications
Infinium BeadChip probe signal intensity and allelic ratio data provide information about copy number changes. By analyzing these signature profiles, deletions (reductions in copy number) and amplifications (increases in copy number) can be readily identified ( Figure 3 ).
Copy-Neutral LOH
The unique ability of SNP genotyping arrays to simultaneously measure intensity differences and allelic ratios allows for the profiling of both DNA copy number and copy-neutral LOH, where loss of heterozygosity occurs with no physical change in the copy number of a particular region ( Figure 3D ).
In tumorigenesis, copy-neutral LOH is thought to arise from mitotic recombination, caused by a rare crossover event during mitotic cell division. The products of mitotic recombination are regions of the genome exhibiting uniparental disomy (UPD), in which both genomic regions originate from the same parent 1 . Only arrays that provide SNP genotyping information can detect copy-neutral events such as UPD, mitotic recombination, or gene conversion events. UPD has already been linked to such disorders as Prader-Willi Syndrome and Angelman Syndrome 2 . Studies using more powerful tools are expected to show that copy-neutral events play a much larger role in tumorigenesis than is currently appreciated 3 .
Mosaicism
The use of SNP arrays for general screening of common aberrations is relatively straightforward. However, results can be confounded by intercellular heterogeneity (also referred to as mosaicism), contamination from normal tissue when analyzing a tumor, or other complex patterns. Because aberrations may not occur in every cell and certain cells may have a normal karyotype while others contain aberrations, identifying mosaics can be labor-intensive. Arrays that provide both genotype and intensity information can extract copy number information in a background of normal cells or in a heterogeneous population of cells ( Figure 4 ). With Illumina SNP arrays, genotyping information in the form of B allele frequency (an allelic composition measurement) can resolve mosaic samples. Using both the log R ratio (based on intensity information) and the B allele frequency parameters, the overall level of mosaicism can be reliably demonstrated, providing insight into the mechanism behind the mosaicism.
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Efficient Screening of Variants
Infinium DNA Analysis BeadChips provide unlimited loci multiplexing and marker design along with high genome-wide SNP coverage for unmatched analysis of structural variation. Combining the multi-sample format with robotic automation enables highly efficient processing. Generated data can be used to characterize common congenital disorders and profile reported CNV regions, while providing dense coverage for novel CNV discovery.
The Power of SNPs
A majority of the markers on Infinium BeadChips consist of SNP genotyping probes. Using SNP genotyping data offers significant advantages for cytogenetic analysis. Since genotypes are essentially digital (allele A or allele B), the data have much higher signal-to-noise ratios (SNR) than if analysis depends exclusively on comparisons between signal intensities. For example, using the Infinium assay ( Figure 5 ), the information derived from the genotypes (B allele frequency) can detect a hemizygous deletion with a SNR of 9 (using a single SNP window). The intensity information alone (log R ratio) provides an SNR of 2 for detecting the same deletion (also using a single SNP window) and is only improved to an SNR of 5 when using a 10-SNP window 4 .
Illumina's robust clustering process and stable Infinium reagent configuration enables precise profiling of copy number changes with genotype information. Furthermore, certain types of structural lesions such as copy-neutral LOH, UPD, mitotic recombination, and gene conversion are only detectable by using SNP genotyping, not array-CGH. Mosaicism is also amenable to study using the SNP markers on Infinium BeadChips because of the combined use of genotyping information and intensity data.
Structural Variant-Targeted Content
In addition to the uniform genome-wide panel of markers, Infinium BeadChips contain specialized content for powerful detection of structural variation and cytogenetic applications ( Table 1 ).
The HumanCytoSNP-12 BeadChip is optimized to efficiently find cytogenetic abnormalities most relevant to human disease. Its content panel includes ~300,000 SNPs targeting common regions shown to be important for cytogenetic analysis 5 . The result is dense coverage of ~250 genomic regions commonly screened in cytogenetics labs, such as the DiGeorge Critical Region, regions linked to neurological syndromes, various development delays, and X-linked syndromes. Additional targeted coverage is in ~400 additional genes, subtelomeric regions, pericentromeric regions, and sex chromosomes. At the same time, genome-wide SNP coverage is kept high (0.79 in CEU at r 2 > 0.8) because the Illumina marker design strategy enables the highest marker efficiency 6 .
The HumanOmniExpress BeadChip provides high sample throughput and comprehensive genomic content at the industry's best price for genome-wide association studies (GWAS). Optimized tag SNP content consisting of >700,000 markers from all three HapMap phases has been strategically selected to capture the greatest amount of common SNP variation at >5% minor allele frequency (MAF) and drive discovery of novel associations with traits and diseases.
The HumanOmni2.5 BeadChip features ~2.4 million markers that capture genomic variation down to 2.5% MAF. Optimized tag SNP content and dense marker spacing (mean spacing = 1.2 kb) enables a broad range of study types, including high resolution for CNV and other structural variation applications.
The HumanOmniExpress and HumanOmni2.5 BeadChips are available with expanded coverage of coding regions. In addition to the current whole-genome content, these exome BeadChips, the HumanOmniExpressExome and HumanOmni2.5Exome, respectively, feature ~245K low-MAF, functional exonic markers. For more information on this exonic content, visit www.illumina.com/exome. The loss of intensity in log R ratio (top plot) indicates a deletion on chromosome 3 in this tumor sample. The genotyping information (bottom plot) shows evidence that this is a mosaic sample. The position of the two central populations of data points (at 0.7 and 0.3), imply that this sample contains 70% normal cells and 30% tumor cells. This mosaic would not have been correctly identified on an array-CGH platform, which provides only intensity information. SNP genotyping data (purple) provides an increased signal-to-noise ratio for detecting some aberrations, compared to using intensity data alone (green). Step 1. Selectivity Step 2. Specificity 
Simplified Workflow
The Infinium assay protocol ( Figure 6 ) features single-tube sample preparation and whole-genome amplification without PCR or ligation steps, significantly reducing labor and sample handling errors. After hybridizing unlabeled DNA sample to the BeadChip, two-step allele detection provides high call rates and accuracy. Selectivity and specificity are accomplished in two steps. Target hybridization to bead-bound 50-mer oligos provides high selectivity and the enzymatic single-base extension provides powerful specificity. The single-base extension also incorporates a labeled nucleotide for assay readout. Intensity and allele data are used to determine regions of structural aberration.
Markers on Infinium BeadChips are present at high feature redundancy, lending to the outstanding data quality and low noise that are hallmarks of Illumina arrays. Low overall noise levels allow reliable detection of single changes in copy number and accurate breakpoint identification 4 . To ensure this standard of quality, every BeadChip is inspected through decode testing.
Comprehensive Kit Configurations
To further streamline the workflow, Infinium products are sold as kits that include BeadChips and all reagents required for processing. Kit sizes range from 16 to 1,152 samples to support efficient use in labs or study designs of all sizes and throughput needs.
Analysis Software
KaryoStudio software is a streamlined version of Illumina's powerful GenomeStudio ® data analysis suite. It allows users to quickly and efficiently identify important structural aberrations, match these to known aberrations, and generate reports based on these findings.
Additionally, illumina•Connect
7 is a collaborative program that facilitates the development of new third-party tools and applications for downstream analysis of data generated using Illumina products. illumina•Connect participants include several current providers of commonly used cytogenetics software.
Conclusion
Infinium BeadChips and the iScan system provide an efficient platform for whole-genome scanning and identification of many classes of point mutations, genomic rearrangements, and structural variants. These BeadChips make use of SNP genotype information along with probe intensity to generate higher signal-to-noise ratios for highly accurate discovery and identification even of low-level variants.
Additional Information
To learn more about Illumina cytogenetics analysis tools, DNA Analysis BeadChips, and sequencing, visit www.illumina.com.
